BIOCONJUGATE INSIGHTS

February 2026 Issue

Volume 1 Issue 1

Bioconjugate Insights Volume 1 Issue 1
Download PDF

Featuring

Issue Spotlight: From bench to bedside: translating ADCs into the clinic
Other articles
Webinar

SPOTLIGHT

From bench to bedside: translating ADCs into the clinic

Podcast

Crossing the ADC inflection points: what separates clinical success from failure

Crossing the ADC inflection points: what separates clinical success from failure

Antoine Yver
23 February
Listen

Interview

Defining immune-active mechanisms of PDL1V in translational ADC development

Defining immune-active mechanisms of PDL1V in translational ADC development

Megan Atkins
19 January
Read

articles

Innovator Insight

Regulatory and CMC considerations for next-generation antibody drug conjugates

Regulatory and CMC considerations for next-generation antibody drug conjugates

Nathan Ihle, Rakesh Dixit
11 February
Read

Event Preview

Event preview of the 5th Novel Conjugates Summit 2026

Event preview of the 5th Novel Conjugates Summit 2026

4 February
Read
NextGen Biomed 2026

NextGen Biomed 2026

28 January
Read
The 16th World ADC London Summit

The 16th World ADC London Summit

21 January
Read

Industry Insights

Industry Insights: Bioconjugate innovation gains momentum across partnerships and pivotal trials

Industry Insights: Bioconjugate innovation gains momentum across partnerships and pivotal trials

Lauren Coyle
19 March
Read
Industry Insights: Converging modalities drive the next wave of bioconjugate therapies

Industry Insights: Converging modalities drive the next wave of bioconjugate therapies

Lauren Coyle
23 January
Read

Webinars